Results 301 to 310 of about 2,224,916 (342)

Adsorptive removal of methylene blue and pharmaceutical effluents using biosynthesized zinc oxide nanoparticles. [PDF]

open access: yesSci Rep
Abouzied AS   +8 more
europepmc   +1 more source

Healthcare utilization and cost analysis by social determinants of health: a prospective cohort study in Catalonia, Spain. [PDF]

open access: yesBMC Health Serv Res
Rodoreda-Pallàs B   +9 more
europepmc   +1 more source

Therapeutic Potential of Exportin 1 and Aurora Kinase A Inhibition in Multiple Myeloma Cells. [PDF]

open access: yesHematol Rep
Okabe S   +6 more
europepmc   +1 more source

Three-Pronged Approach (Active Pharmaceutical Ingredients, Excipients, and NOx-Free Air) Successfully Suppressed the Formation of Nitroso-atomoxetine to 0.097 ppm

open access: hybrid
R. NOMURA   +8 more
openalex   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Pharmaceutical Virtue

Culture, Medicine and Psychiatry, 2006
In the early history of psychopharmacology, the prospect of developing technologically sophisticated drugs to alleviate human ills was surrounded with a fervor that could be described as religious. This paper explores the subsequent history of the development of psychopharmacological agents, focusing on the ambivalent position of both the industry and ...
openaire   +2 more sources

Pharmaceutical care

Pharmacy World and Science, 1996
Drug-treatment failures can be prevented by applying a Pharmaceutical Care system. Therapeutic outcome monitoring is such a system, which can be applied to the (drug) treatment of several diseases like asthma, diabetes and cardiovascular diseases. Pharmaceutical Care is an outcome oriented, cooperative, systematic approach to providing drug therapy ...
openaire   +2 more sources

Pharmaceutical Proteomics

Annals of the New York Academy of Sciences, 2000
Abstract: Genomics and proteomics are today well established in drug discovery and, in combination with combinatorial chemistry and high‐throughput screening, are helping to bring forward an unprecedented number of potential lead compounds. To avoid the generation of bottlenecks downstream in drug development, increasing pressure is arising to ...
S, Steiner, N L, Anderson
openaire   +2 more sources

Home - About - Disclaimer - Privacy